TR200002641T2 - Viral yayılma ve çoğalma için ortam ve yöntem - Google Patents

Viral yayılma ve çoğalma için ortam ve yöntem

Info

Publication number
TR200002641T2
TR200002641T2 TR200002641T TR200002641T TR200002641T2 TR 200002641 T2 TR200002641 T2 TR 200002641T2 TR 200002641 T TR200002641 T TR 200002641T TR 200002641 T TR200002641 T TR 200002641T TR 200002641 T2 TR200002641 T2 TR 200002641T2
Authority
TR
Turkey
Prior art keywords
proliferation
environment
viral spread
proteins
viral
Prior art date
Application number
TR200002641T
Other languages
English (en)
Inventor
Heimindiger Pierre
Original Assignee
Aventis Pasteur
Merial S.A.S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pasteur, Merial S.A.S. filed Critical Aventis Pasteur
Publication of TR200002641T2 publication Critical patent/TR200002641T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0043—Medium free of human- or animal-derived components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/76—Undefined extracts from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32651—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Mevcut bulusun konusu, kültürlenmis hücre üzerinde viral yayilma ve büyüme için bir ortam olup belirleyici özelligi, hayvan veya insan proteinlerinden arindirilmis olmasi; mitojenik potansiyeli olan ve 1000 ila 200,000 dalton arasi bir moleküler agirligi olan, patatesten veya hiyardan çikarilmis proteinleri veya glikoproteinleri içermesidir.
TR200002641T 1998-03-13 1999-03-15 Viral yayılma ve çoğalma için ortam ve yöntem TR200002641T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9803333A FR2775983B1 (fr) 1998-03-13 1998-03-13 Milieu et procede de propagation et de multiplication virales

Publications (1)

Publication Number Publication Date
TR200002641T2 true TR200002641T2 (tr) 2000-11-21

Family

ID=9524203

Family Applications (1)

Application Number Title Priority Date Filing Date
TR200002641T TR200002641T2 (tr) 1998-03-13 1999-03-15 Viral yayılma ve çoğalma için ortam ve yöntem

Country Status (16)

Country Link
EP (1) EP1062324A2 (tr)
JP (1) JP2002506636A (tr)
KR (1) KR20010072556A (tr)
CN (1) CN1301297A (tr)
AU (1) AU752577B2 (tr)
BR (1) BR9908744A (tr)
CA (1) CA2322619A1 (tr)
EA (1) EA200000934A1 (tr)
FR (1) FR2775983B1 (tr)
HU (1) HUP0101081A3 (tr)
IL (1) IL138250A0 (tr)
NZ (1) NZ506872A (tr)
PL (1) PL343557A1 (tr)
SK (1) SK12882000A3 (tr)
TR (1) TR200002641T2 (tr)
WO (1) WO1999047648A2 (tr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000083657A (ja) * 1998-07-13 2000-03-28 Chemo Sero Therapeut Res Inst 日本脳炎ウイルスワクチン
AT409379B (de) 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
EP1381673B1 (en) * 2001-03-27 2009-05-13 Vertex Pharmaceuticals Incorporated Compositions and methods useful for hcv infection
ES2398706T3 (es) * 2002-07-09 2013-03-21 Baxter International Inc. Medio exento de proteínas animales para el cultivo de células
GB0304799D0 (en) 2003-03-03 2003-04-09 Glaxosmithkline Biolog Sa Novel method
US20060094104A1 (en) 2004-10-29 2006-05-04 Leopold Grillberger Animal protein-free media for cultivation of cells
ES2474573T3 (es) 2006-01-04 2014-07-09 Baxter International Inc Medio de cultivo celular sin oligop�ptidos
JP5458536B2 (ja) * 2008-09-17 2014-04-02 不二製油株式会社 乳酸の製造方法及び乳酸発酵用添加剤
CN107129963A (zh) * 2017-04-24 2017-09-05 浙江美保龙生物技术有限公司 一种df‑1细胞培养液添加剂及其制备方法、使用方法
CN107043739A (zh) * 2017-04-24 2017-08-15 浙江美保龙生物技术有限公司 一种Vero细胞培养液添加剂及其制备方法、使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5498537A (en) * 1994-03-09 1996-03-12 Cellco, Inc. Serum-free production of packaged viral vector
FR2732347A1 (fr) * 1995-03-30 1996-10-04 Bio Media Extrait vegetal, son procede de preparation et ses applications en medecine humaine ou veterinaire
CN1226831A (zh) * 1997-04-16 1999-08-25 菲瓦公开有限公司 蔬菜提取物及其制备方法和其在人类及兽医学中的应用

Also Published As

Publication number Publication date
AU2735299A (en) 1999-10-11
JP2002506636A (ja) 2002-03-05
KR20010072556A (ko) 2001-07-31
HUP0101081A2 (hu) 2001-07-30
IL138250A0 (en) 2001-10-31
SK12882000A3 (sk) 2001-05-10
WO1999047648A2 (fr) 1999-09-23
HUP0101081A3 (en) 2003-04-28
WO1999047648A3 (fr) 1999-11-04
NZ506872A (en) 2002-03-01
CA2322619A1 (en) 1999-09-23
EA200000934A1 (ru) 2001-02-26
BR9908744A (pt) 2000-12-26
CN1301297A (zh) 2001-06-27
FR2775983A1 (fr) 1999-09-17
AU752577B2 (en) 2002-09-26
PL343557A1 (en) 2001-08-27
FR2775983B1 (fr) 2000-11-10
EP1062324A2 (fr) 2000-12-27

Similar Documents

Publication Publication Date Title
ATE133181T1 (de) Dehydrodidemnin b
FR2800984B1 (fr) Dispositif de remplacement d'une valve cardiaque par voie percutanee
TR199801532T2 (tr) Insan TNFalfa 'sini baglayan insan antikorlari.
ATE286118T1 (de) Anwendungen für humane nicht autologe, mesenchymale stammzellen
TR200002641T2 (tr) Viral yayılma ve çoğalma için ortam ve yöntem
DE3750422D1 (de) Translation von mrna.
NZ227788A (en) Peptide having growth hormone regulatory effects, and compositions
BR0010989A (pt) Plantas e células de plantas geneticamente modificadas com uma atividade aumentada de uma proteìna de amilossacarase e uma enzima de ramificação
CY1110490T1 (el) Πεπτιδια που σχετιζονται με το συν-πολυμερες (copolymer) 1 για χρηση σαν παραγοντες σημανσης μοριακου βαρους και για θεραπευτικη χρηση
HK1042052A1 (zh) 內皮血管生長因子-2
UA27035C2 (uk) Кристал білка, зшитого багатофуhкціоhальhим зшивальним агеhтом (варіаhти), пристрій, що містить кристал білка та спосіб отримаhhя аспартаму
DE69920031D1 (de) Verwendung von vegf-c und vegf-d genen oder proteinen zur vorbeugung der restenose
PL342568A1 (en) Deep-frozen article of food
ATE433461T1 (de) Rana pipiens proteine und deren verwendung in der behandlung von tumoren
DE69837337D1 (de) Herstellung von proteinen in eiern
DE69736858D1 (de) Unsterbliche vogelzellen
TR200002101T2 (tr) Dondurulmuş gıda ürünü.
DE59410132D1 (de) Humanes zirkulierendes cytokin cc-1
DE60102147D1 (de) Anti-gefrier proteine, deren herstellung und verwendung
DE69110060D1 (de) In der humantherapie nützliche substanzen peptidischer natur.
IT1270618B (it) Proteine ad attivita' antitumorale
Péan Mammoth and subsistence practices during the mid upper palaeolithic of Central Europe (Moravia, Czech Republic)
TR199801027T2 (tr) Epitelyom teshis ve tedavisi için yöntem.
ATE374246T1 (de) Polypeptidfragmente mit einem c-terminalen teil von katalase aus helicobacter
DK0848757T3 (da) Anvendelse af WAP eller MMTV regulatoriske sekvenser for målrettet ekspression af sammenkædede heterologe gener i humane mammae celler, inklusiv humane mammae carcinoma celler